Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 30;12(10):1908-1912.
doi: 10.21037/tp-23-368. Epub 2023 Oct 20.

Fever and neutropenia in pediatric oncology and stem cell transplant patients: an editorial commentary on updated international clinical practice guidelines

Alex Hoover  1 , Beth K Thielen  2 , Christen L Ebens  3
Affiliations
Editorial

Fever and neutropenia in pediatric oncology and stem cell transplant patients: an editorial commentary on updated international clinical practice guidelines

Alex Hoover et al. Transl Pediatr. .
No abstract available

Keywords: Cellular therapies; cell-free DNA; resource-constrained.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-368/coif). AH is supported by the National Institute of Health – National Research Service Award (NIH-NRSA) Research Fellowship in Translational & Genomic Pediatric Cancer Epidemiology (No. T32CA099936). BKT has received grant funding from Merck, the Immune Deficiency Foundation, and the Centers for Disease Control and Prevention; honoraria from Horizon, Seegene, and Sanofi; and travel support from the Doximity Foundation. CLE is a consultant with Elixirgen Therapeutics, Inc. and is supported by the National Institutes of Health’s National Center for Advancing Translational Sciences (NIH NCATS) (Nos. KL2TR002492 and UL1TR002494). The authors have no other conflicts of interest to declare.

Comment on

References

    1. Lehrnbecher T, Robinson PD, Ammann RA, et al. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. J Clin Oncol 2023;41:1774-85. 10.1200/JCO.22.02224 - DOI - PMC - PubMed
    1. Lehrnbecher T, Phillips R, Alexander S, et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 2012;30:4427-38. 10.1200/JCO.2012.42.7161 - DOI - PubMed
    1. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol 2017;35:2082-94. 10.1200/JCO.2016.71.7017 - DOI - PubMed
    1. Kumar A, Biswas B, Chopra A, et al. Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study). Indian J Pediatr 2021;88:240-5. 10.1007/s12098-020-03377-x - DOI - PubMed
    1. Santolaya ME, Alvarez AM, Acuña M, et al. Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial. Clin Microbiol Infect 2017;23:173-8. 10.1016/j.cmi.2016.11.001 - DOI - PMC - PubMed